{"id":10381,"date":"2009-10-02T03:37:12","date_gmt":"2009-10-02T07:37:12","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=10381"},"modified":"2009-10-03T03:37:33","modified_gmt":"2009-10-03T07:37:33","slug":"osteonecrosis-del-maxilar-onm-asociada-a-bisfosfonatos","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/10381","title":{"rendered":"Osteonecrosis del Maxilar (ONM) Asociada a Bisfosfonatos"},"content":{"rendered":"<p>Estimados colegas les env\u00edo una Nota Informativa de la Agencia Espa\u00f1ola de Medicamentos (AGEMED) y la Agencia Europea de Medicamentos (EMEA) sobre las recomendaciones para prevenir la Osteonecrosis del Maxilar asociada a Bisfosfonatos, les sugiero las revisen con detenimiento ya que en Dermatolog\u00eda es com\u00fan su uso para prevenir la osteoporosis por corticoides.<\/p>\n<p><!--more-->___________<br \/>\n Descargar archivo adjunto en formato PDF:<\/p>\n<p><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2009\/10\/bisfosfonatos-y-osteonecrosis-del-Maxilar.pdf\">bisfosfonatos y osteonecrosis del Maxilar.pdf<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Estimados colegas les env\u00edo una Nota Informativa de la Agencia Espa\u00f1ola de Medicamentos (AGEMED) y la Agencia Europea de Medicamentos (EMEA) sobre las recomendaciones para prevenir la Osteonecrosis del Maxilar asociada a Bisfosfonatos, les sugiero las revisen con detenimiento ya que en Dermatolog\u00eda es com\u00fan su uso para prevenir la osteoporosis por corticoides.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-10381","post","type-post","status-publish","format-standard","","category-farmacologia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/10381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=10381"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/10381\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=10381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=10381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=10381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}